Vestis (VSTS) Q2 2026 Earnings Transcript

Vestis reported Q2 revenue of $659 million, down 0.9%, but adjusted EBITDA rose 19% to $74.5 million and net income improved to $2.6 million from a $27.8 million loss. Management raised full-year adjusted EBITDA guidance to $295 million-$325 million from $285 million-$315 million and boosted free cash flow guidance to $120 million-$150 million from $50 million-$60 million. The company also generated $45.6 million of quarterly free cash flow, repaid $34 million of debt, and ended with $344 million of liquidity.

Analysis

The key signal is not the modest revenue decline; it is that Vestis is now generating real operating leverage from a cleaner mix, and that leverage is likely to persist for several quarters even if top-line growth remains choppy. The company is effectively harvesting margin from its existing base through pricing floors, customer pruning, and tighter service economics, which should compress the gap between reported EBITDA and cash earnings as the restructuring matures.

The second-order effect is competitive: if Vestis is willing to let low-quality volume walk, that forces a reallocation of customer share toward higher-discipline operators and creates a narrow window where incumbents with better service density can capture accounts without chasing bad pricing. That is structurally favorable for CTAS and, to a lesser extent, UNF if they can avoid the temptation to mirror Vestis’ price resets too aggressively; the real risk is a local price war in overlapping routes if managements conclude they can defend share with incremental service rather than margin.

The biggest misconception is that this is just a turnaround story for a laggard. It is also a balance-sheet optionality story: with liquidity ample and debt maturities pushed out, management now has time to use asset sales, working-capital release, and mix improvement to re-rate the equity before topline growth fully inflects. The market may be underestimating how much of FY27 will be set by the Q4 exit rate; if EBITDA run-rate exits north of the implied guidance band, the stock can move on multiple expansion well before revenue turns visibly positive.

Main tail risk: the company is still walking a narrow line between disciplined pricing and over-pruning, and if volume drops faster than expected in Q3, the market will punish the name for mistaking shrinkage for quality. The catalyst sequence is clear: Q3 should validate sequential EBITDA, Q4 should confirm growth inflection, and FY27 guidance will decide whether this is a sustainable margin compounding story or just a one-year reset.

Key Decisions for Investors

• Go long VSTS into the next 1-2 earnings prints with a 3-6 month horizon; the setup is asymmetrically positive if Q4 exit EBITDA prints near the top of the guided range, but size modestly because the trade is still execution-sensitive.
• Pair long VSTS / short ARMK for 1-2 quarters; the relative story favors the name with cleaner operating leverage and balance-sheet repair, while ARMK carries more exposure to slower mix improvement and lower near-term optionality.
• Use call spreads on VSTS rather than outright equity if entering before the next quarter; this captures the upside from multiple expansion on a guidance beat while limiting downside if volume pruning proves more disruptive than expected.
• For more defensive exposure to the same industry theme, rotate incremental capital toward CTAS on pullbacks; if Vestis succeeds in resetting pricing discipline, Cintas is the better-quality beneficiary with lower reinvestment risk and more durable compounding.
• Avoid shorting UNF solely on the basis of Vestis weakness; the better short is the segment of the market that will be forced to defend share with discounting, not the names with stronger route density and pricing power.